April 3, 2024Molecular Medicine ReportsOpen Access

Research progress on oncoprotein hepatitis B X‑interacting protein (Review)

View Full Paper

Ask AI

Bookmark

Hepatitis b x-interacting protein promotes tumor progression by regulating cellular transcription, enhancing antioxidant defenses, and suppressing ferroptosis in multiple cancers.
Narrative review characterizes Lamtor-encoded oncoprotein activity across breast cancer, hepatocellular carcinoma, and esophageal squamous cell carcinoma without quantitative pooling.
Highlights metabolic reprogramming driven by the oncoprotein as a key mechanism, calling for targeted clinical evaluations across diverse malignant tumor environments.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Literature review reveals oncogenic mechanisms of hepatitis B X-interacting protein across multiple tumor types, highlighting its therapeutic potential in cancer progression.

Cite This Study

Cheng et al. (2024) studied this question.

synapsesocial.com/papers/68e709f1b6db643587683668 https://doi.org/10.3892/mmr.2024.13213

View Full Paper

Ask AI

Bookmark

Implication

Literature review reveals oncogenic mechanisms of hepatitis B X-interacting protein across multiple tumor types, highlighting its therapeutic potential in cancer progression.

Research progress on oncoprotein hepatitis B X‑interacting protein (Review)

Key Points

Discussion

Implication

Cite This Study

Research progress on oncoprotein hepatitis B X‑interacting protein (Review)

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider